home built analysis tool Search Results


built-in multiple variable analysis tool graphpad prism 9  (GraphPad Software Inc)
90
GraphPad Software Inc built-in multiple variable analysis tool graphpad prism 9
Built In Multiple Variable Analysis Tool Graphpad Prism 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/built-in multiple variable analysis tool graphpad prism 9/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
built-in multiple variable analysis tool graphpad prism 9 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
in-built analysis tool and report editor abet ii  (Campden Instruments)
90
Campden Instruments in-built analysis tool and report editor abet ii
In Built Analysis Tool And Report Editor Abet Ii, supplied by Campden Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in-built analysis tool and report editor abet ii/product/Campden Instruments
Average 90 stars, based on 1 article reviews
in-built analysis tool and report editor abet ii - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
cellminer analysis tool ( http://discover.nci.nih.gov/cellminer/home.do )  (Novartis)
90
Novartis cellminer analysis tool ( http://discover.nci.nih.gov/cellminer/home.do )
Increased Nrf2 expression in human gliomas and in glioma progression. ( a ) BioGPS database shows Nrf2 expression in different human tissues. Brain tissue shows, with exception of the pineal gland, intermediate to low expression levels compared to thyroid and epithelial cells. ( b ) <t>CellMiner</t> analysis of Nrf2 expression in the NCI60 tumor cell lines panel. ( c ) Comparison of 81 GBM specimens and 23 normal brain tissue samples (Oncomine) for Nrf2 mRNA expression. GBM tissues show a significant ( P =8.67 × 10 −11 ) higher expression of Nrf2. ( d ), Rembrandt database analysis of survival rates from glioma patients with different Nrf2 expression levels. Red line=upregulation of Nrf2 >2 × (41 samples), yellow=intermediate (302 samples), blue=all glioma (427 samples). Nrf2 upregulation leads to significant ( P =0.007) poorer overall survival rates.
Cellminer Analysis Tool ( Http://Discover.Nci.Nih.Gov/Cellminer/Home.Do ), supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellminer analysis tool ( http://discover.nci.nih.gov/cellminer/home.do )/product/Novartis
Average 90 stars, based on 1 article reviews
cellminer analysis tool ( http://discover.nci.nih.gov/cellminer/home.do ) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
built-in depth analysis tool  (Veeco)
90
Veeco built-in depth analysis tool
Increased Nrf2 expression in human gliomas and in glioma progression. ( a ) BioGPS database shows Nrf2 expression in different human tissues. Brain tissue shows, with exception of the pineal gland, intermediate to low expression levels compared to thyroid and epithelial cells. ( b ) <t>CellMiner</t> analysis of Nrf2 expression in the NCI60 tumor cell lines panel. ( c ) Comparison of 81 GBM specimens and 23 normal brain tissue samples (Oncomine) for Nrf2 mRNA expression. GBM tissues show a significant ( P =8.67 × 10 −11 ) higher expression of Nrf2. ( d ), Rembrandt database analysis of survival rates from glioma patients with different Nrf2 expression levels. Red line=upregulation of Nrf2 >2 × (41 samples), yellow=intermediate (302 samples), blue=all glioma (427 samples). Nrf2 upregulation leads to significant ( P =0.007) poorer overall survival rates.
Built In Depth Analysis Tool, supplied by Veeco, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/built-in depth analysis tool/product/Veeco
Average 90 stars, based on 1 article reviews
built-in depth analysis tool - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
in-built twoway analysis of variance (anova) tool  (Compusense Inc)
90
Compusense Inc in-built twoway analysis of variance (anova) tool
Increased Nrf2 expression in human gliomas and in glioma progression. ( a ) BioGPS database shows Nrf2 expression in different human tissues. Brain tissue shows, with exception of the pineal gland, intermediate to low expression levels compared to thyroid and epithelial cells. ( b ) <t>CellMiner</t> analysis of Nrf2 expression in the NCI60 tumor cell lines panel. ( c ) Comparison of 81 GBM specimens and 23 normal brain tissue samples (Oncomine) for Nrf2 mRNA expression. GBM tissues show a significant ( P =8.67 × 10 −11 ) higher expression of Nrf2. ( d ), Rembrandt database analysis of survival rates from glioma patients with different Nrf2 expression levels. Red line=upregulation of Nrf2 >2 × (41 samples), yellow=intermediate (302 samples), blue=all glioma (427 samples). Nrf2 upregulation leads to significant ( P =0.007) poorer overall survival rates.
In Built Twoway Analysis Of Variance (Anova) Tool, supplied by Compusense Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in-built twoway analysis of variance (anova) tool/product/Compusense Inc
Average 90 stars, based on 1 article reviews
in-built twoway analysis of variance (anova) tool - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
in-house–built semiautomated analysis software tool accurate idl version 8.4  (Harris Geospatial Solutions)
90
Harris Geospatial Solutions in-house–built semiautomated analysis software tool accurate idl version 8.4
Increased Nrf2 expression in human gliomas and in glioma progression. ( a ) BioGPS database shows Nrf2 expression in different human tissues. Brain tissue shows, with exception of the pineal gland, intermediate to low expression levels compared to thyroid and epithelial cells. ( b ) <t>CellMiner</t> analysis of Nrf2 expression in the NCI60 tumor cell lines panel. ( c ) Comparison of 81 GBM specimens and 23 normal brain tissue samples (Oncomine) for Nrf2 mRNA expression. GBM tissues show a significant ( P =8.67 × 10 −11 ) higher expression of Nrf2. ( d ), Rembrandt database analysis of survival rates from glioma patients with different Nrf2 expression levels. Red line=upregulation of Nrf2 >2 × (41 samples), yellow=intermediate (302 samples), blue=all glioma (427 samples). Nrf2 upregulation leads to significant ( P =0.007) poorer overall survival rates.
In House–Built Semiautomated Analysis Software Tool Accurate Idl Version 8.4, supplied by Harris Geospatial Solutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in-house–built semiautomated analysis software tool accurate idl version 8.4/product/Harris Geospatial Solutions
Average 90 stars, based on 1 article reviews
in-house–built semiautomated analysis software tool accurate idl version 8.4 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
in-built analysis tool  (GraphPad Software Inc)
90
GraphPad Software Inc in-built analysis tool
Increased Nrf2 expression in human gliomas and in glioma progression. ( a ) BioGPS database shows Nrf2 expression in different human tissues. Brain tissue shows, with exception of the pineal gland, intermediate to low expression levels compared to thyroid and epithelial cells. ( b ) <t>CellMiner</t> analysis of Nrf2 expression in the NCI60 tumor cell lines panel. ( c ) Comparison of 81 GBM specimens and 23 normal brain tissue samples (Oncomine) for Nrf2 mRNA expression. GBM tissues show a significant ( P =8.67 × 10 −11 ) higher expression of Nrf2. ( d ), Rembrandt database analysis of survival rates from glioma patients with different Nrf2 expression levels. Red line=upregulation of Nrf2 >2 × (41 samples), yellow=intermediate (302 samples), blue=all glioma (427 samples). Nrf2 upregulation leads to significant ( P =0.007) poorer overall survival rates.
In Built Analysis Tool, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in-built analysis tool/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
in-built analysis tool - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Increased Nrf2 expression in human gliomas and in glioma progression. ( a ) BioGPS database shows Nrf2 expression in different human tissues. Brain tissue shows, with exception of the pineal gland, intermediate to low expression levels compared to thyroid and epithelial cells. ( b ) CellMiner analysis of Nrf2 expression in the NCI60 tumor cell lines panel. ( c ) Comparison of 81 GBM specimens and 23 normal brain tissue samples (Oncomine) for Nrf2 mRNA expression. GBM tissues show a significant ( P =8.67 × 10 −11 ) higher expression of Nrf2. ( d ), Rembrandt database analysis of survival rates from glioma patients with different Nrf2 expression levels. Red line=upregulation of Nrf2 >2 × (41 samples), yellow=intermediate (302 samples), blue=all glioma (427 samples). Nrf2 upregulation leads to significant ( P =0.007) poorer overall survival rates.

Journal: Oncogenesis

Article Title: Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis

doi: 10.1038/oncsis.2017.65

Figure Lengend Snippet: Increased Nrf2 expression in human gliomas and in glioma progression. ( a ) BioGPS database shows Nrf2 expression in different human tissues. Brain tissue shows, with exception of the pineal gland, intermediate to low expression levels compared to thyroid and epithelial cells. ( b ) CellMiner analysis of Nrf2 expression in the NCI60 tumor cell lines panel. ( c ) Comparison of 81 GBM specimens and 23 normal brain tissue samples (Oncomine) for Nrf2 mRNA expression. GBM tissues show a significant ( P =8.67 × 10 −11 ) higher expression of Nrf2. ( d ), Rembrandt database analysis of survival rates from glioma patients with different Nrf2 expression levels. Red line=upregulation of Nrf2 >2 × (41 samples), yellow=intermediate (302 samples), blue=all glioma (427 samples). Nrf2 upregulation leads to significant ( P =0.007) poorer overall survival rates.

Article Snippet: Analysis of Nrf2 expression in different tissues and cell lines was performed with the Novartis database BioGPS ( http://biogps.org ) and the CellMiner analysis tool ( http://discover.nci.nih.gov/cellminer/home.do ).

Techniques: Expressing